Black Rock Inc. Vanda Pharmaceuticals Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,138,252 shares of VNDA stock, worth $38.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,138,252
Previous 8,139,881
0.02%
Holding current value
$38.2 Million
Previous $33.5 Million
37.45%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding VNDA
# of Institutions
155Shares Held
44.9MCall Options Held
136KPut Options Held
220K-
Jim Simons Renaissance Technologies LLC | New York, Ny4.11MShares$19.3 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$16.1 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.15MShares$10.1 Million1.49% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.01MShares$9.44 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.98MShares$9.3 Million0.03% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $265M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...